The Gateway Pundit has published a sponsored post urging readers to avoid being “caught with an empty medicine cabinet” and to instead build what it describes as an American six-month stockpile of ivermectin, arguing that dependence on Chinese supply lines leaves consumers vulnerable.
The piece, labeled as a promoted post and accompanied by a disclosure thanking readers for supporting advertisers, is the latest in a series of sponsored health-product messages on the site. It appears under a headline warning readers not to be caught unprepared, with a direct appeal to purchase through links that financially benefit the outlet.
“Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit,” the disclosure reads.
A Stockpile Pitch Tied to Supply Chain Anxiety
The sponsored message leans heavily on concerns about pharmaceutical manufacturing concentration overseas, particularly in China, and presents domestic sourcing as the solution. It encourages readers to secure a six-month personal supply of ivermectin — a drug that became a flashpoint during the COVID-19 pandemic — as a preparedness measure.
Ivermectin is an FDA-approved medication for specific parasitic infections, and its use as a COVID-19 treatment has been repeatedly rejected by major health agencies. Its inclusion in a sponsored stockpile pitch reflects how the drug has remained a fixture in certain political-media ecosystems, where it is often framed as a symbol of medical autonomy and skepticism toward federal health guidance.
The post carries a clear medical disclaimer: “The information provided on this website is intended for informational purposes only and should not be considered medical advice or used as a substitute for professional healthcare guidance.” It also places responsibility on the reader to follow laws governing prescription medications.
That caveat matters because ivermectin is a prescription drug in the United States, and buying or stockpiling it outside normal medical channels can raise legal and safety questions. The sponsored post does not include dosing instructions, clinical guidance, or a named medical professional endorsing the product.
Sponsored Content Blurs Lines Between News and Advertising
The Gateway Pundit has long mixed editorial content with sponsored messages, a practice common among digital publishers but one that can create confusion for readers who may not immediately distinguish between news reporting and paid promotion. This particular piece is explicitly labeled as a promoted post at the top, and the outlet invites readers to email the Promoted Post account or read more of its sponsored articles.
For a politics-focused audience, the framing is notable: it links personal medical preparedness to broader anxieties about foreign manufacturing and national self-sufficiency. The message that an “American” ivermectin supply is preferable to one dependent on Chinese supply lines echoes themes that have circulated in conservative media around pharmaceutical sourcing, drug shortages, and distrust of global supply chains.
Whether such stockpiling is practical, legal, or medically advisable is a separate question. The sponsored post itself offers no evidence of a specific supply disruption, no data on Chinese production of ivermectin, and no details about the manufacturer or seller behind the American-made product it promotes.
What the Post Doesn’t Say
There is no independent verification in the piece of the claims about supply origins or product quality. It does not name a pharmaceutical company, cite regulatory approvals, or provide a price, quantity, or sourcing breakdown beyond the general promise of an American supply.
Instead, it relies on urgency and a preparedness frame — the idea that readers should act now before they find themselves without medication. That approach is typical of direct-response marketing, where scarcity and self-reliance are used to drive purchases.
The disclaimer also notes that readers are responsible for complying with “all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.” That language effectively shifts legal responsibility to the buyer, which is standard in supplement and gray-market pharmaceutical advertising.
For readers who encounter the post, the practical takeaways are limited: it is a paid advertisement, not a news article; it promotes a prescription drug without clinical guidance; and it frames stockpiling as a political and personal preparedness statement. The outlet’s own disclosure makes clear that the message is sponsored, and the medical disclaimer makes clear that it is not medical advice.
The Gateway Pundit did not publish additional reporting alongside the promoted post, and the sponsored message stands alone as an advertisement within the site’s feed. Readers looking for verified information on ivermectin, its approved uses, or pharmaceutical supply chains would need to consult sources outside the sponsored content.
Source: www.thegatewaypundit.com — https://www.thegatewaypundit.com/2026/09/dont-get-caught-empty-medicine-cabinet-chinese-supply/